肿瘤内微生物研究进展
Research Progress of Intratumoral Microbiota
DOI: 10.12677/acm.2024.1492564, PDF,   
作者: 张艺馨, 弓 云:西安医学院,陕西 西安;李 佳, 杨 红*:西京医院妇产科,陕西 西安
关键词: 肿瘤内微生物肿瘤微环境诊断抗肿瘤治疗预后Intratumoral Microbiota Tumor Microenvironment Diagnosis Antineoplastic Therapy Prognosis
摘要: 肿瘤内微生物是肿瘤微环境的潜在组成部分,由于它们的低生物量和其他障碍,人们对其知之甚少。随着一些技术如组学和免疫学方法被用于肿瘤内微生物群的研究,曾经被认为是无菌的肿瘤组织实际上是多种微生物的宿主。微生物群可以通过粘膜破坏、邻近组织迁移和血液侵袭等方式定植肿瘤组织,从而影响肿瘤的生物学行为。对肿瘤内微生物群的更全面、更深入的认识不断涌现。本文就肿瘤内微生物的概念、发展历史、潜在来源进行了广泛的回顾,探讨了微生物在肿瘤诊断、预后以及抗肿瘤治疗中的临床作用,并对该领域未来可能的研究进行了展望。
Abstract: Intratumoral microbes are potential components of the tumor microenvironment that are poorly understood due to their low biomass and other barriers. As several techniques such as omics and immunological approaches have been used to study the intratumoral microbiota, tumor tissues, once considered sterile, are in fact host to a variety of microorganisms. Microbiota can colonize tumor tissues through mucosal destruction, adjacent tissue migration, and blood invasion, thus affecting the biological behavior of tumors. A more comprehensive and in-depth understanding of the tumor microbiome continues to emerge. This article reviews the concept, development history and potential sources of tumor microorganisms, discusses the clinical role of microorganisms in tumor diagnosis, prognosis and anti-tumor therapy, and prospects the possible future research in this field.
文章引用:张艺馨, 李佳, 弓云, 杨红. 肿瘤内微生物研究进展[J]. 临床医学进展, 2024, 14(9): 1042-1048. https://doi.org/10.12677/acm.2024.1492564

参考文献

[1] Sender, R., Fuchs, S. and Milo, R. (2016) Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell, 164, 337-340. [Google Scholar] [CrossRef] [PubMed]
[2] Sender, R., Fuchs, S. and Milo, R. (2016) Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLOS Biology, 14, e1002533. [Google Scholar] [CrossRef] [PubMed]
[3] Azevedo, M.M., Pina-Vaz, C. and Baltazar, F. (2020) Microbes and Cancer: Friends or Faux? International Journal of Molecular Sciences, 21, Article No. 3115. [Google Scholar] [CrossRef] [PubMed]
[4] Wong-Rolle, A., Wei, H.K., Zhao, C. and Jin, C. (2020) Unexpected Guests in the Tumor Microenvironment: Microbiome in Cancer. Protein & Cell, 12, 426-435. [Google Scholar] [CrossRef] [PubMed]
[5] Gagliani, N., Hu, B., Huber, S., Elinav, E. and Flavell, R.A. (2014) The Fire Within: Microbes Inflame Tumors. Cell, 157, 776-783. [Google Scholar] [CrossRef] [PubMed]
[6] Nejman, D., Livyatan, I., Fuks, G., Gavert, N., Zwang, Y., Geller, L.T., et al. (2020) The Human Tumor Microbiome Is Composed of Tumor Type-specific Intracellular Bacteria. Science, 368, 973-980. [Google Scholar] [CrossRef] [PubMed]
[7] Poore, G.D., Kopylova, E., Zhu, Q., Carpenter, C., Fraraccio, S., Wandro, S., et al. (2020) Retracted Article: Microbiome Analyses of Blood and Tissues Suggest Cancer Diagnostic Approach. Nature, 579, 567-574. [Google Scholar] [CrossRef] [PubMed]
[8] Kalaora, S., Nagler, A., Nejman, D., Alon, M., Barbolin, C., Barnea, E., et al. (2021) Identification of Bacteria-Derived Hla-Bound Peptides in Melanoma. Nature, 592, 138-143. [Google Scholar] [CrossRef] [PubMed]
[9] Galeano Niño, J.L., Wu, H., LaCourse, K.D., Kempchinsky, A.G., Baryiames, A., Barber, B., et al. (2022) Effect of the Intratumoral Microbiota on Spatial and Cellular Heterogeneity in Cancer. Nature, 611, 810-817. [Google Scholar] [CrossRef] [PubMed]
[10] Dohlman, A.B., Klug, J., Mesko, M., Gao, I.H., Lipkin, S.M., Shen, X., et al. (2022) A Pan-Cancer Mycobiome Analysis Reveals Fungal Involvement in Gastrointestinal and Lung Tumors. Cell, 185, 3807-3822.e12. [Google Scholar] [CrossRef] [PubMed]
[11] Narunsky-Haziza, L., Sepich-Poore, G.D., Livyatan, I., Asraf, O., Martino, C., Nejman, D., et al. (2022) Pan-cancer Analyses Reveal Cancer-Type-Specific Fungal Ecologies and Bacteriome Interactions. Cell, 185, 3789-3806.e17. [Google Scholar] [CrossRef] [PubMed]
[12] Elinav, E., Garrett, W.S., Trinchieri, G. and Wargo, J. (2019) The Cancer Microbiome. Nature Reviews Cancer, 19, 371-376. [Google Scholar] [CrossRef] [PubMed]
[13] Xie, Y., Xie, F., Zhou, X., Zhang, L., Yang, B., Huang, J., et al. (2022) Microbiota in Tumors: From Understanding to Application. Advanced Science, 9, e2200470. [Google Scholar] [CrossRef] [PubMed]
[14] Garrett, W.S. (2015) Cancer and the Microbiota. Science, 348, 80-86. [Google Scholar] [CrossRef] [PubMed]
[15] Walker, S.P., Tangney, M. and Claesson, M.J. (2020) Sequence-Based Characterization of Intratumoral Bacteria—A Guide to Best Practice. Frontiers in Oncology, 10, Article No. 179. [Google Scholar] [CrossRef] [PubMed]
[16] Hieken, T.J., Chen, J., Hoskin, T.L., Walther-Antonio, M., Johnson, S., Ramaker, S., et al. (2016) The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease. Scientific Reports, 6, Article No. 30751. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, X., Wang, A., Chu, A., Gong, Y. and Yuan, Y. (2019) Mucosa-Associated Microbiota in Gastric Cancer Tissues Compared with Non-Cancer Tissues. Frontiers in Microbiology, 10, Article No. 1261. [Google Scholar] [CrossRef] [PubMed]
[18] Castellarin, M., Warren, R.L., Freeman, J.D., Dreolini, L., Krzywinski, M., Strauss, J., et al. (2011) Fusobacterium nucleatum Infection Is Prevalent in Human Colorectal Carcinoma. Genome Research, 22, 299-306. [Google Scholar] [CrossRef] [PubMed]
[19] Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., et al. (2013) Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment. Cell Host & Microbe, 14, 207-215. [Google Scholar] [CrossRef] [PubMed]
[20] Wang, Y., Du, J., Wu, X., Abdelrehem, A., Ren, Y., Liu, C., et al. (2021) Crosstalk between Autophagy and Microbiota in Cancer Progression. Molecular Cancer, 20, Article No. 163. [Google Scholar] [CrossRef] [PubMed]
[21] Tzeng, A., Sangwan, N., Jia, M., Liu, C., Keslar, K.S., Downs-Kelly, E., et al. (2021) Human Breast Microbiome Correlates with Prognostic Features and Immunological Signatures in Breast Cancer. Genome Medicine, 13, Article No. 60. [Google Scholar] [CrossRef] [PubMed]
[22] Yang, W., Chen, C., Jia, M., Xing, X., Gao, L., Tsai, H., et al. (2021) Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma. Frontiers in Cell and Developmental Biology, 9, Article ID: 641270. [Google Scholar] [CrossRef] [PubMed]
[23] Chu, C., Yang, C., Yeh, C., Lin, R., Chen, C., Bai, L., et al. (2022) Endoscopic Ultrasound-Guided Fine-Needle Biopsy as a Tool for Studying the Intra-Tumoral Microbiome in Pancreatic Ductal Adenocarcinoma: A Pilot Study. Scientific Reports, 12, Article No. 107. [Google Scholar] [CrossRef] [PubMed]
[24] Gomes, S., Cavadas, B., Ferreira, J.C., Marques, P.I., Monteiro, C., Sucena, M., et al. (2019) Profiling of Lung Microbiota Discloses Differences in Adenocarcinoma and Squamous Cell Carcinoma. Scientific Reports, 9, Article No. 12838. [Google Scholar] [CrossRef] [PubMed]
[25] Qiao, H., Tan, X., Li, H., Li, J., Chen, X., Li, Y., et al. (2022) Association of Intratumoral Microbiota with Prognosis in Patients with Nasopharyngeal Carcinoma from 2 Hospitals in China. JAMA Oncology, 8, 1301-1309. [Google Scholar] [CrossRef] [PubMed]
[26] Sun, L., Ke, X., Guan, A., Jin, B., Qu, J., Wang, Y., et al. (2023) Intratumoural Microbiome Can Predict the Prognosis of Hepatocellular Carcinoma after Surgery. Clinical and Translational Medicine, 13, e1331. [Google Scholar] [CrossRef] [PubMed]
[27] Fallone, C.A., Chiba, N., van Zanten, S.V., Fischbach, L., Gisbert, J.P., Hunt, R.H., et al. (2016) The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology, 151, 51-69.e14. [Google Scholar] [CrossRef] [PubMed]
[28] Choi, I.J., Kim, C.G., Lee, J.Y., et al. (2020) Family History of Gastric Cancer and Helicobacter pylori Treatment. New England Journal of Medicine, 382, 2170-2172.
[29] Roche, B., Coilly, A., Duclos‐Vallee, J.C. and Samuel, D. (2018) The Impact of Treatment of Hepatitis C with DAAS on the Occurrence of HCC. Liver International, 38, 139-145. [Google Scholar] [CrossRef] [PubMed]
[30] Lowy, D.R. and Schiller, J.T. (2017) Preventing Cancer and Other Diseases Caused by Human Papillomavirus Infection: 2017 Lasker-DeBakey Clinical Research Award. JAMA, 318, 901-902. [Google Scholar] [CrossRef] [PubMed]
[31] Geller, L.T., Barzily-Rokni, M., Danino, T., Jonas, O.H., Shental, N., Nejman, D., et al. (2017) Potential Role of Intratumor Bacteria in Mediating Tumor Resistance to the Chemotherapeutic Drug Gemcitabine. Science, 357, 1156-1160. [Google Scholar] [CrossRef] [PubMed]
[32] Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., et al. (2017) Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell, 170, 548-563.e16. [Google Scholar] [CrossRef] [PubMed]
[33] Mohindroo, C., Hasanov, M., Rogers, J.E., Dong, W., Prakash, L.R., Baydogan, S., et al. (2021) Antibiotic Use Influences Outcomes in Advanced Pancreatic Adenocarcinoma Patients. Cancer Medicine, 10, 5041-5050. [Google Scholar] [CrossRef] [PubMed]
[34] Bernardo, G., Le Noci, V., Ottaviano, E., De Cecco, L., Camisaschi, C., Guglielmetti, S., et al. (2023) Reduction of Staphylococcus Epidermidis in the Mammary Tumor Microbiota Induces Antitumor Immunity and Decreases Breast Cancer Aggressiveness. Cancer Letters, 555, Article ID: 216041. [Google Scholar] [CrossRef] [PubMed]
[35] Lurienne, L., Cervesi, J., Duhalde, L., de Gunzburg, J., Andremont, A., Zalcman, G., et al. (2020) NSCLC Immunotherapy Efficacy and Antibiotic Use: A Systematic Review and Meta-analysis. Journal of Thoracic Oncology, 15, 1147-1159. [Google Scholar] [CrossRef] [PubMed]
[36] Jing, Y., Chen, X., Li, K., Liu, Y., Zhang, Z., Chen, Y., et al. (2022) Association of Antibiotic Treatment with Immune-Related Adverse Events in Patients with Cancer Receiving Immunotherapy. Journal for ImmunoTherapy of Cancer, 10, e003779. [Google Scholar] [CrossRef] [PubMed]
[37] Kabwe, M., Dashper, S., Bachrach, G. and Tucci, J. (2021) Bacteriophage Manipulation of the Microbiome Associated with Tumour Microenvironments-Can This Improve Cancer Therapeutic Response? FEMS Microbiology Reviews, 45, fuab017. [Google Scholar] [CrossRef] [PubMed]
[38] Dolgin, E. (2020) Fighting Cancer with Microbes. Nature, 577, S16-S18. [Google Scholar] [CrossRef] [PubMed]
[39] Zheng, D., Dong, X., Pan, P., Chen, K., Fan, J., Cheng, S., et al. (2019) Phage-Guided Modulation of the Gut Microbiota of Mouse Models of Colorectal Cancer Augments Their Responses to Chemotherapy. Nature Biomedical Engineering, 3, 717-728. [Google Scholar] [CrossRef] [PubMed]
[40] Gogokhia, L., Buhrke, K., Bell, R., Hoffman, B., Brown, D.G., Hanke-Gogokhia, C., et al. (2019) Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis. Cell Host & Microbe, 25, 285-299.e8. [Google Scholar] [CrossRef] [PubMed]
[41] Sinha, A., Li, Y., Mirzaei, M.K., Shamash, M., Samadfam, R., King, I.L., et al. (2022) Transplantation of Bacteriophages from Ulcerative Colitis Patients Shifts the Gut Bacteriome and Exacerbates the Severity of DSS Colitis. Microbiome, 10, Article No. 105. [Google Scholar] [CrossRef] [PubMed]